Neurology Devices Market to Reach USD 43.28 Billion by 2033 | CAGR 6.2% | North America Leads with 38% Share | Key Players: Medtronic, Boston Scientific, Stryker, Abbott, Johnson & Johnson

Neurology Devices Market Size and Growth

The global neurology devices market was valued at US$ 23.95 billion in 2023, increased to US$ 25.30 billion in 2024, and is projected to reach US$ 43.28 billion by 2033, growing at a CAGR of 6.2% during 2025-2033.

The market growth is primarily driven by the rising prevalence of neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and stroke, which continue to impose a substantial global health burden. In addition, technological advancements in diagnostic and therapeutic devices, including neurostimulation systems, neurosurgical tools, and brain monitoring devices, are revolutionizing patient outcomes and expanding treatment options. Furthermore, increasing healthcare infrastructure investments, the growing aging population, and greater awareness of early diagnosis and treatment of neurological conditions are fueling global demand. Emerging trends such as AI-assisted diagnostics, wearable neuro-monitoring systems, and minimally invasive neurosurgical devices are expected to create new growth opportunities in the coming years.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/neurology-devices-market?Juli

Recent Developments:

✅ December 2025: Medtronic launched its next-generation deep brain stimulation (DBS) system, featuring AI-based adaptive stimulation technology to improve precision in treating Parkinson's disease and movement disorders.

✅ October 2025: Abbott announced the FDA approval of its EternaTM Spinal Cord Stimulation (SCS) system, the smallest implantable, rechargeable neurostimulator designed for chronic pain management.

✅ August 2025: Boston Scientific introduced an upgraded version of its Vercise Genus DBS system, integrating real-time brain signal recording to optimize therapy for neurological patients.

✅ June 2025: Stryker unveiled its neurosurgical navigation platform with AR/VR integration, improving intraoperative precision and enhancing surgeon visualization during complex brain and spine procedures.

✅ April 2025: NeuroPace received CE Mark approval for its RNS® System in Europe, enabling responsive neurostimulation therapy for epilepsy patients with uncontrolled seizures.

✅ February 2025: Penumbra introduced the Access25 delivery microcatheter, a single-lumen medical device designed to assist physicians in navigating the neurovasculature for precise delivery of Penumbra's advanced 0.020-inch coil platform.

✅ February 2024: Royal Philips unveiled major upgrades to its Image Guided Therapy System, an advanced interventional platform aimed at improving clinical productivity, accelerating decision-making, increasing patient throughput, and enhancing overall treatment outcomes.

Mergers & Acquisitions:

✅ November 2025: Medtronic acquired a U.S.-based neurotechnology startup specializing in AI-driven neuroimaging and brain-computer interface systems to enhance its neuromodulation and diagnostics portfolio.

✅ September 2025: Abbott Laboratories completed the acquisition of NeuroSigma Inc., a leading developer of trigeminal nerve stimulation devices for neurological and psychiatric disorders, strengthening its neuromodulation offerings.

✅ July 2025: Boston Scientific acquired Nexeon MedSystems Inc., expanding its capabilities in implantable neuromodulation systems and bioelectronic therapies.

✅ May 2025: Stryker announced the acquisition of ClearPoint Neuro's neurosurgical navigation assets, enhancing its portfolio of image-guided technologies for minimally invasive brain procedures.

✅ March 2025: Zimmer Biomet partnered with Neuralink Technologies to co-develop next-generation brain-computer interface (BCI) devices aimed at restoring motor functions in patients with neurological injuries.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=neurology-devices-market?Juli

Key Players:
Stryker | Boston Scientific Corporation | Integra LifeSciences Holdings Corporation | Johnson & Johnson | Medtronic | Penumbra Inc. | Abbott | NIHON KOHDEN CORPORATION | B. Braun SE | MicroPort Scientific Corporation

Key Highlights:

• Medtronic - Holds a 16.8% share, leading the global market with its extensive range of neuromodulation and deep brain stimulation (DBS) devices for the treatment of Parkinson's disease, epilepsy, and chronic pain.

• Boston Scientific Corporation - Holds a 15.2% share, driven by its advanced DBS and spinal cord stimulation systems designed to enhance precision therapy for neurological disorders.

• Stryker - Holds a 13.6% share, supported by innovative neurosurgical equipment, navigation systems, and AI-integrated technologies for brain and spine procedures.

• Abbott - Holds a 12.1% share, fueled by strong performance in neuromodulation and neurostimulation solutions, including its FDA-approved EternaTM SCS system.

• Johnson & Johnson - Holds a 10.4% share, leveraging its neurosurgical tools and devices for minimally invasive brain and spine surgeries through its DePuy Synthes division.

• Integra LifeSciences Holdings Corporation - Holds an 8.9% share, focusing on neuro-critical care and neurosurgery solutions, including dural repair and cranial stabilization systems.

• Penumbra Inc. - Holds a 7.6% share, driven by its strong position in neurovascular devices and stroke intervention technologies.

• NIHON KOHDEN CORPORATION - Holds a 6.4% share, supported by its advanced neurodiagnostic and monitoring devices for EEG and EMG applications.

• B. Braun SE - Holds a 5.2% share, offering neurosurgical instruments and solutions for brain and spinal procedures with a focus on safety and precision.

• MicroPort Scientific Corporation - Holds a 3.8% share, expanding its neuromodulation and minimally invasive surgical device offerings across Asia-Pacific and emerging markets.

Market Segmentation:

➥ By Product, Neurostimulation Devices dominate the market with a 38% share, driven by the rising use of deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators in treating neurological disorders such as Parkinson's disease, epilepsy, and chronic pain. Interventional Neurology Devices hold a 25% share, supported by the growing demand for thrombectomy devices, stents, and embolic coils for stroke management. Neurosurgery Devices account for 20%, fueled by technological advancements in navigation, imaging, and robotic-assisted surgical tools. Cerebrospinal Fluid (CSF) Management Devices represent 10%, primarily used in managing hydrocephalus and related disorders, while Others contribute 7%, including monitoring systems and diagnostic tools.

➥ By Disease Type, Ischemic Strokes lead with a 40% share, owing to the increasing global prevalence of stroke cases and growing adoption of interventional neurology procedures. Cerebral Aneurysms account for 25%, driven by the need for minimally invasive treatment solutions. Carotid Artery Stenosis holds 15%, with demand supported by diagnostic advancements and endovascular treatment options. Fistulas and Arteriovenous Malformations (AVMs) contribute 10%, while Others (including traumatic brain injuries and tumors) represent the remaining 10% of the market.

➥ By End-User, Hospitals & Clinics dominate with a 55% share, attributed to the availability of advanced neurology equipment, skilled professionals, and comprehensive treatment facilities. Specialty Centers hold 30%, supported by the growing number of dedicated neuro and stroke centers focusing on advanced diagnosis and treatment. Others, including ambulatory surgical centers and research institutions, account for 15%, reflecting increasing adoption of specialized neurology devices in outpatient and academic settings.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/neurology-devices-market?Juli

Market Dynamics:

Driver: Rising Prevalence of Neurological Disorders
The increasing prevalence of neurological disorders is a major factor driving the growth of the neurology devices market. According to Yale Medicine, approximately 795,000 Americans experience a stroke each year, with nearly 87% classified as ischemic strokes. The incidence is notably higher among adults aged 65 and older, highlighting the strong correlation between aging and neurological disease risk.

Additionally, conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and stroke are becoming increasingly common across both developed and developing countries. This growing burden of neurological disorders is driving demand for advanced diagnostic, monitoring, and therapeutic devices that improve clinical outcomes and enhance patient care. As the global population continues to age, healthcare systems are prioritizing early detection and treatment of neurological diseases, further accelerating market growth.

Restraint: High Cost of Therapy
The high cost associated with neurology devices and treatment procedures remains a key barrier to market expansion, particularly in low- and middle-income regions. Sophisticated technologies such as implantable neurostimulation devices, neuroimaging systems, and wearable monitoring equipment require significant investment not only for procurement but also for ongoing maintenance and technical support.

Regional Insights:

North America dominates the global neurology devices market with a 38% share (USD 9.61 billion in 2024), driven by advanced healthcare infrastructure, a high prevalence of neurological disorders, and strong R&D investments in neurotechnology. The United States leads the region, supported by extensive adoption of neurostimulation and neuromodulation devices, as well as significant funding for brain health research and clinical trials. Favorable reimbursement policies and a growing elderly population further bolster regional growth.

Europe holds a 27% share (USD 6.83 billion in 2024), supported by the increasing incidence of Alzheimer's and Parkinson's disease, expanding geriatric demographics, and government initiatives promoting neurological care. Countries such as Germany, France, and the UK are major contributors, with robust healthcare systems adopting advanced neuro-monitoring, imaging, and surgical devices to improve patient outcomes.

Asia-Pacific is the fastest-growing region, accounting for 25% of the market (USD 6.32 billion in 2024), with a projected CAGR exceeding 7.5% during 2025-2033. Growth is driven by improving healthcare infrastructure, increasing public awareness, and rising healthcare expenditure in countries like China, Japan, South Korea, and India. The growing burden of stroke and epilepsy, coupled with greater access to advanced medical technologies, is accelerating adoption across hospitals and specialty centers.

Latin America, Middle East & Africa (LAMEA) represent 10% of the market (USD 2.53 billion in 2024). Growth in this region is supported by ongoing healthcare modernization, government support for advanced medical device imports, and rising prevalence of neurological disorders. Key markets include Brazil, Mexico, Saudi Arabia, and South Africa, where healthcare systems are gradually expanding access to advanced neurology diagnostics and treatment technologies.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.